NEW YORK-A tiny scaffold created to prop open arteries after angioplasty procedures may help prevent restenosis-a reoccurring thickening of the cardiovascular arteries and vessels.
The scaffold, also known as a stent, has been perfected by Boston Scientific-a medical company based in Natick, Mass. Company researchers added a coating of the drug paclitaxel to the stent before using them in a clinical trail of patients who were undergoing angioplasty.
The results showed that none of the 31 patients who received the coated stet later developed restenosis. In the second group, 30 patients received the same stent without the coating and 11% developed the condition. There were no adverse events reported.
The company reports testing will continue on a larger scale and the stent is expected to be launched in Europe in 2002. It is expected to be on the American market by 2003.
For more information about Boston Scientific, log onto: www.bsci.com.
Information from www.latimes.com
IDEA in Action: A Strategic Approach to Contamination Control
January 14th 2025Adopting IDEA—identify, define, explain, apply—streamlines contamination control. Infection control professionals can mitigate risks through prevention, intervention, and training, ensuring safer health care environments and reducing frequent contamination challenges.
Balancing Freedom and Safety: When Public Health Mandates Are Necessary
January 9th 2025Public health mandates, such as lockdowns, masking, and vaccination, balance liberty and safety, ensuring critical protections during pandemics like COVID-19 while fostering long-term survival through science.
Long-Term Chronicles: Infection Surveillance Guidance in Long-Term Care Facilities
January 8th 2025Antibiotic stewardship in long-term care facilities relies on McGeer and Loeb criteria to guide infection surveillance and appropriate prescribing, ensuring better outcomes for residents and reducing resistance.
Considering Avian Flu: World Health Organization Expert Warns Against Raw Milk
January 6th 2025Drinking raw milk poses risks of disease transmission, especially with H5N1 outbreaks. Expert Richard J. Webby, PhD, advises against raw cow or goat milk consumption due to its unpredictable and significant risks.